Marjorie Dehlinger

951 total citations
12 papers, 639 citations indexed

About

Marjorie Dehlinger is a scholar working on Infectious Diseases, Virology and Speech and Hearing. According to data from OpenAlex, Marjorie Dehlinger has authored 12 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Virology and 1 paper in Speech and Hearing. Recurrent topics in Marjorie Dehlinger's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (10 papers). Marjorie Dehlinger is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (10 papers). Marjorie Dehlinger collaborates with scholars based in United States, South Africa and Italy. Marjorie Dehlinger's co-authors include Ian Sanne, Matthew P. Fox, Charles van der Horst, Robin Wood, Francesca Conradie, Jennifer Zeinecker, Prudence Ive, Catherine Orrell, Mohammed Rassool and James McIntyre and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Clinical Infectious Diseases.

In The Last Decade

Marjorie Dehlinger

12 papers receiving 614 citations

Peers

Marjorie Dehlinger

VIROL

EPIDE

PPCH

Rita Lyamuya United States

B. H. Zambia

Henri Mukumbi Democratic Republic of the Congo

Kevin De Cock United States

Claire Graber Switzerland

Teguest Guerma Switzerland

Ndèye Fatou Ngom Gueye Senegal

Valérie Journot France

Peter Arimi United States

Jennifer Zeinecker South Africa

Rita Lyamuya United States

Marjorie Dehlinger

394 ×0.8

145 ×0.4

VIROL

212 ×1.3

EPIDE

87 ×0.8

92 ×1.1

PPCH

Citations per year, relative to Marjorie Dehlinger Marjorie Dehlinger (= 1×) peers Rita Lyamuya

Countries citing papers authored by Marjorie Dehlinger

Since Specialization

Citations

This map shows the geographic impact of Marjorie Dehlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Dehlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Dehlinger more than expected).

Fields of papers citing papers by Marjorie Dehlinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Dehlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Dehlinger. The network helps show where Marjorie Dehlinger may publish in the future.

Co-authorship network of co-authors of Marjorie Dehlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Dehlinger. A scholar is included among the top collaborators of Marjorie Dehlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Dehlinger. Marjorie Dehlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Wood, Robin, Ian Sanne, James McIntyre, et al.. (2020). Initiating Patients on ART at CD4 Counts above 200 is Associated with Improved Treatment Outcomes in South Africa. UNC Libraries. 1 indexed citations

Robbins, Gregory K., Susan E. Cohn, Linda Harrison, et al.. (2016). Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251. HIV Clinical Trials. 17(4). 165–172. 11 indexed citations

Haas, David W., Daniel R. Kuritzkes, Marylyn D. Ritchie, et al.. (2011). Pharmacogenomics of HIV Therapy: Summary of a Workshop Sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials. 12(5). 277–285. 10 indexed citations

Sanne, Ian, Catherine Orrell, Matthew P. Fox, et al.. (2010). Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. The Lancet. 376(9734). 33–40. 190 indexed citations

Fox, Matthew P., Ian Sanne, Francesca Conradie, et al.. (2010). Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa. AIDS. 24(13). 2041–2050. 61 indexed citations

Flexner, Charles, Camlin Tierney, Robert Gross, et al.. (2010). Comparison of Once‐Daily versus Twice‐Daily Combination Antiretroviral Therapy in Treatment‐Naive Patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48‐Week Randomized Controlled Trial. Clinical Infectious Diseases. 50(7). 1041–1052. 40 indexed citations

Fischl, Margaret A., Ann C. Collier, Aprateem Mukherjee, et al.. (2007). Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. AIDS. 21(3). 325–333. 20 indexed citations

MacArthur, Rodger D., Richard M. Novak, Grace Peng, et al.. (2006). A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. The Lancet. 368(9553). 2125–2135. 101 indexed citations

MacArthur, Rodger D., Grace Peng, Richard Novák, et al.. (2004). Efficacy and Safety of Abacavir Plus Lamivudine Versus Didanosine Plus Stavudine When Combined with a Protease Inhibitor, a Nonnucleoside Reverse Transcriptase Inhibitor, or Both in HIV-1 Positive Antiretroviral-Naive Persons. HIV Clinical Trials. 5(6). 361–370. 10 indexed citations

10.

Fischl, Margaret A., Heather J. Ribaudo, Ann C. Collier, et al.. (2003). A Randomized Trial of 2 Different 4‐Drug Antiretroviral Regimens versus a 3‐Drug Regimen, in Advanced Human Immunodeficiency Virus Disease. The Journal of Infectious Diseases. 188(5). 625–634. 69 indexed citations

11.

Albrecht, Mary, Ronald J. Bosch, Scott M. Hammer, et al.. (2001). Nelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV Infection. New England Journal of Medicine. 345(6). 398–407. 94 indexed citations

12.

Jacobson, Mark Z., Chantal M.A.M. van der Horst, Dennis Causey, et al.. (1991). In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053). The Journal of Infectious Diseases. 163(6). 1219–1222. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact